Aging populations, sedentary lifestyles, and urbanization contribute to increasing rates of metabolic disorders, creating a larger target patient pool for GLP-1 therapies
In septic ICU patients with elevated lactate, treatment with vitamin C and thiamine lowered hospital mortality, showing the strongest benefit when both were given together, especially in vasopressor-dependent cases (Byerly et al., 2020)
Combination therapy with GIP and GLP-1 enhances the incretin effect to improve dysglycaemia through increased prandial insulin secretion, reducing postprandial glycaemic excursions
Administered to humans as part of an experiment or investigation
Why Consider Switching from Semaglutide to Tirzepatide
They also tend to experience more pronounced nausea with GLP-1 medications